- Home
- NODK vs HUMA Comparison
NODK vs HUMA Comparison
Compare NODK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NODK
- HUMA
- Stock Information
- Founded
- NODK 1946
- HUMA 2004
- Country
- NODK United States
- HUMA United States
- Employees
- NODK N/A
- HUMA N/A
- Industry
- NODK Property-Casualty Insurers
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- NODK Finance
- HUMA Health Care
- Exchange
- NODK Nasdaq
- HUMA Nasdaq
- Market Cap
- NODK 277.0M
- HUMA 250.2M
- IPO Year
- NODK 2017
- HUMA N/A
- Fundamental
- Price
- NODK $14.01
- HUMA $1.85
- Analyst Decision
- NODK
- HUMA Strong Buy
- Analyst Count
- NODK 0
- HUMA 8
- Target Price
- NODK N/A
- HUMA $10.88
- AVG Volume (30 Days)
- NODK 10.8K
- HUMA 2.9M
- Earning Date
- NODK 11-06-2025
- HUMA 11-07-2025
- Dividend Yield
- NODK N/A
- HUMA N/A
- EPS Growth
- NODK N/A
- HUMA N/A
- EPS
- NODK 0.07
- HUMA N/A
- Revenue
- NODK $310,389,000.00
- HUMA $818,000.00
- Revenue This Year
- NODK N/A
- HUMA N/A
- Revenue Next Year
- NODK N/A
- HUMA $1,619.38
- P/E Ratio
- NODK $195.82
- HUMA N/A
- Revenue Growth
- NODK N/A
- HUMA N/A
- 52 Week Low
- NODK $12.01
- HUMA $1.15
- 52 Week High
- NODK $17.24
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- NODK 64.08
- HUMA 59.04
- Support Level
- NODK $13.13
- HUMA $1.45
- Resistance Level
- NODK $14.34
- HUMA $1.53
- Average True Range (ATR)
- NODK 0.30
- HUMA 0.10
- MACD
- NODK 0.07
- HUMA 0.06
- Stochastic Oscillator
- NODK 77.85
- HUMA 94.90
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.